Hedge Fund Manager Kyle Bass Is Going After Big Pharma And Their 'BS Patents'
REUTERS/Brendan McDermidTexan hedge fund manager Kyle Bass is going activist against the U.S. pharmaceutical industry and their patents, according to @finansakrobat's Twitter feed.
"We'll have a separate pharmacy vehicle. We've dedicated half of our resources over the past six months to this," Bass told conference attendees.
Bass, the founder of Hayman Capital, was speaking at the Skagen New Year's Conference in Copenhagen.
Bass told conference attendees that he plans to file IPR petitions (inter partes reviews) to challenge drugmaker patents.
"This will change the way pharma companies [manage] their BS patents," Bass said, according to @finansakrobat.
We reached out to Hayman Capital for more on the presentation.
In the meantime, here's a great rundown courtesy of @finansakrobat's Twitter feed.
- 6 reasons why you should visit Ladakh this summer
- TVS iQube gets a new variant priced under ₹1 lakh, ST variant gets a bigger battery
- As English players begin their premature IPL exodus, Gavaskar calls for action against England Cricket Board
- Top 10 destinations for river rafting in India in 2024
- Should you enrol your child in an online university like IGNOU?
- Nothing Phone (2a) blue edition launched
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market